The Immature Heart: The Roles of Bone Marrow Stromal Stem Cells in Growth and Myocardial Repair

Jun Luo, Duong Minh, Wan Calvin, Teng Carolyn J, Chiu Ray C.j, Shum-Tim DominiqueThe Open Cardiovascular Medicine Journal 2007 · DOI

TL;DR

This study investigates whether bone marrow stromal cells (MSCs) can contribute to the growth and repair of immature hearts after birth, a question previously unaddressed. The findings indicate that while MSCs don't promote normal growth in post-natal hearts, they can effectively home to and help repair damaged myocardium in both immature and adult hearts, suggesting a potential therapeutic avenue for pediatric cardiac injury.

What Problem Does This Paper Address?

While it's established that adult bone marrow stromal cells (MSCs) can aid in repairing damaged adult hearts and contribute to cardiac growth during fetal development, their role in the post-natal immature heart remains unclear. This is a critical knowledge gap, especially considering the prevalence of congenital heart defects and cardiomyopathies in infants, which often lead to heart failure. The authors aim to determine if MSCs can participate in the normal growth of immature hearts or contribute to the repair of myocardial injury in this vulnerable age group.

Methods

The researchers used a syngeneic Lewis rat model, employing adult Lewis rats as both donors and recipients to mimic autologous transplantation. MSCs were isolated from adult rats and genetically modified with a Lac-Z reporter gene using retroviral vectors for tracking. These labeled MSCs were then systemically injected into three groups of rats: neonatal (2 days old), immature (30 days old), and adult (>3 months old). To assess repair capabilities, a subset of immature and adult rats underwent left coronary artery ligation to induce myocardial infarction. Hearts were harvested at various time points (2 days to 6 weeks) and stained with X-Gal to visualize labeled MSCs. Additionally, immunohistochemical staining for cardiomyocyte markers (Troponin I-C and Connexin-43) was performed to evaluate differentiation.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • MSC Homing is Universal, but Repair is Context-Dependent: MSCs consistently homed to the bone marrow in all age groups, regardless of whether the heart was injured or not. However, their recruitment to the myocardium for repair was only observed in hearts that had sustained injury (coronary artery ligation).
  • No Growth Promotion in Post-Natal Hearts: Contrary to their role in fetal development, MSCs did not appear to contribute to the normal growth of non-injured hearts in the post-natal period. This suggests a fundamental difference in how cardiac growth is regulated before and after birth.
  • Potential for Myocardial Regeneration: The study provides strong evidence that MSCs can differentiate into cardiomyocyte phenotypes and contribute to the regeneration of damaged myocardium in both immature and adult hearts following injury.
  • Implications for Pediatric Cardiac Therapy: The findings highlight that MSC-based therapies might be beneficial for repairing cardiac damage in infants and children, even though they may not stimulate normal cardiac growth.

Key Results

  • Labeled MSCs were successfully detected in the bone marrow of all recipient rats across all age groups, from 2 days to 6 weeks post-injection.
  • In rats with induced myocardial infarction (groups AL and BL), labeled MSCs were recruited to the infarcted areas of the myocardium.
  • In these injured hearts, MSCs demonstrated cardiomyogenic differentiation, expressing Troponin I-C and Connexin-43.
  • No labeled MSCs were detected in the hearts of rats without induced injury, across all age groups.
  • Body weights of immature and newborn rats significantly increased over the 3-week period, but this growth was not attributed to MSCs in non-injured hearts.

Limitations and Future Work

The authors acknowledge several limitations:

  • Cell Fusion: The study did not specifically investigate whether MSCs fuse with existing cardiomyocytes, a mechanism that has been proposed for stem cell-mediated regeneration.
  • Cell Surface Markers: The study did not fractionate MSCs based on specific cell surface markers, which could lead to heterogeneity in the transplanted cell population.
  • Quantitative Analysis: The proportion of implanted cells that survived and differentiated was not quantitatively assessed.
  • Functional Effects: The study did not evaluate the functional impact of MSC therapy on immature hearts.

Future work could focus on addressing these limitations, particularly by quantitatively assessing the therapeutic benefits and exploring the precise mechanisms of MSC migration and differentiation in the immature heart. Further investigation into the potential for MSCs to prevent abnormal cardiac growth in utero is also warranted.

Summary updated

Abstract

Studies have shown that adult bone marrow derived stem cells (MSCs) can participate in repair of myocardial injury in adult hearts, as well as in cardiac growth during fetal development in utero. Yet, no studies have evaluated the role of MSCs with respect to normal growth or tissue repair in immature hearts after birth. The present study examines whether MSCs may participate in the myocardial growth and injury in the post-natal immature hearts. MSCs were isolated from adult Lewis rats and labeled with Lac-Z gene using retroviral vectors. These MSCs were injected systemically into groups of neonatal (NB=2days-old), immature (B=30days-old) and adult (A=>3months-old) isogeneic Lewis rats. Additionally, left coronary artery ligation was carried out in subgroups of immature (BL) and adult (AL) rats one week after MSCs injection. The hearts were harvested serially from 2-days to 6-weeks, stained with X-Gal for labeled MSCs. Cardiomyocyte phenotypic expression was evaluated by immunohistological staining for Troponin I-C and Connexin-43. Labeled MSCs were found to home into the bone marrow in all rats of different developmental stages. They could be recruited from bone marrow into the infarcted site of myocardium only in groups AL and BL. They were also capable of differentiating into cardiomyocyte phenotype after myocardial injury. In contrast to that reported in the developing fetus, MSCs did not appear to contribute to the growth of non-injured hearts after birth. However, they can be recruited from the bone marrow and regenerate damaged myocardium both in the adult and in the immature hearts.
BibTeX
@article{luo2007immature,
  author = {Jun Luo and Duong Minh and Wan Calvin and Teng Carolyn J and Chiu Ray C.J and Shum-Tim Dominique},
  title = {{The Immature Heart: The Roles of Bone Marrow Stromal Stem Cells in Growth and Myocardial Repair}},
  journal = {The Open Cardiovascular Medicine Journal},
  year = {2007},
  doi = {10.2174/1874192400701010027},
}
Figure